The table tells an important story
High purity, research grade Retatrutide
In the largest clinical study, participants lost an average of almost 15% of their initial body weight after taking semaglutide GLP-1
Phase 2 trial results demonstrating mean weight loss of 24.2% at 48 weeks establish retatrutide as the most efficacious anti-obesity agent tested to date, with ongoing Phase 3 trials poised to confirm long-term outcomes
Buyers interested in Omzo's other programs - including the brand's published HB-01 Hormone Balance Formula for women, the compounded ED and men's wellness performance programs (positioned under the brand's men's health category), or the hair and skin categories - should visit omzo.com directly for current program details, pricing, and eligibility criteria for those categories
Goal-weight maintenance + sustainable exit plan